Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Change in Cash (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Change in Cash for 3 consecutive years, with $65.2 million as the latest value for Q4 2025.

  • Quarterly Change in Cash rose 1046.28% to $65.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $128.4 million through Dec 2025, up 1953.35% year-over-year, with the annual reading at $128.4 million for FY2025, 1953.35% up from the prior year.
  • Change in Cash for Q4 2025 was $65.2 million at Nuvation Bio, up from -$149.1 million in the prior quarter.
  • The five-year high for Change in Cash was $200.0 million in Q2 2025, with the low at -$149.1 million in Q3 2025.
  • Average Change in Cash over 3 years is $5.2 million, with a median of $2.7 million recorded in 2024.
  • Peak annual rise in Change in Cash hit 88985.78% in 2025, while the deepest fall reached 3408.43% in 2025.
  • Over 3 years, Change in Cash stood at $18.3 million in 2023, then plummeted by 68.85% to $5.7 million in 2024, then soared by 1046.28% to $65.2 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at $65.2 million, -$149.1 million, and $200.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.